Abbreviations

Abbreviations

GMB

Adult glioblastoma

pHGG

Paediatric high-grade glioma

UNCAN

EU initiative for understanding cancer

MRI

Magnetic resonance imaging 

SOC

Standard of care

I/O

Immuno-oncology

TTF

Tumour treating fields

Highlights from partner talks at EANO 2026

Chiara (image on the right) presented research mapping how the glioblastoma tumour ecosystem changes during treatment. The study, conducted with GLIOMATCH support, identified distinct patterns of change associated with patient outcomes. Chiara also presented a poster on the cellular architecture of newly diagnosed glioblastoma.

Frederik (image on the left) presented the IC4 atlas of patient-derived cell lines, a resource for studying primary and metastatic central nervous system tumours. 

Follow GLIOMATCH on LinkedIn and Facebook for more information on brain tumour research and updates on our milestones towards improving the clinical outcomes of GBM and pHGG.

More Posts

GLIOMATCH: Explained with Dr. Chiara Caprioli and Prof. Frederik De Smet

In this GLIOMATCH: Explained episode, Dr. Chiara Caprioli and Prof. Frederik De Smet from KU Leuven explain how new research has mapped the evolution of glioblastoma from diagnosis to recurrence, identified distinct tumour trajectories and established a framework that could support more personalised treatment decisions.

GLIOMATCH: Explained with Prof. Dr. Sandra Jacobs

In this GLIOMATCH: Explained episode, Prof. Dr. Sandra Jacobs introduces the paediatric clinical study, the participating centres and the challenges of working with archived samples from paediatric high-grade glioma patients.

GLIOMATCH marks World Brain Tumour Day at EU event on advancing brain cancer research

On World Brain Tumour Day 2026, GLIOMATCH participated in the European event “Advancing Brain Cancer Research: From policy action to scientific breakthroughs” at the European Parliament in Strasbourg. The event highlighted the urgent need to accelerate brain cancer research, strengthen European collaboration and turn scientific progress into improved care for patients.